Stockscreener 앱 받기
105.13
0.77%
-0.82
시간 외 거래:
105.82
0.69
+0.66%
전일 마감가:
$105.95
열려 있는:
$107.47
하루 거래량:
417.33K
Relative Volume:
0.42
시가총액:
$3.02B
수익:
$267.23M
순이익/손실:
$-83.50M
주가수익비율:
-33.80
EPS:
-3.11
순현금흐름:
$-59.99M
1주 성능:
+3.47%
1개월 성능:
+23.36%
6개월 성능:
+76.57%
1년 성능:
+220.23%
1일 변동 폭
$102.97
$108.41
1주일 범위
$101.10
$109.10
52주 변동 폭
$28.86
$117.75
Genedx Holdings Corp Stock (WGS) Company Profile
명칭
Genedx Holdings Corp
전화
888-729-1206
주소
333 LUDLOW STREET, STAMFORD
WGS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
105.13 | 3.04B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
460.72 | 169.53B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
200.56 | 139.75B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
658.06 | 49.94B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
114.62 | 32.16B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
179.86 | 30.17B | 15.50B | 1.33B | 2.16B | 7.34 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-09 | 개시 | Piper Sandler | Overweight |
| 2025-05-15 | 개시 | Guggenheim | Buy |
| 2025-05-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-07-10 | 개시 | Craig Hallum | Buy |
| 2024-06-03 | 재개 | Jefferies | Hold |
모두보기
Genedx Holdings Corp 주식(WGS)의 최신 뉴스
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are - Bluefield Daily Telegraph
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Rosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action InvestigationWGS - Barchart.com
WGS Investor News: If You Have Suffered Losses in GeneDx - GlobeNewswire
Should You Buy GeneDx Holdings Corp. (WGS) After Golden Cross? - Zacks Investment Research
Industry Analysts Just Upgraded Their GeneDx Holdings Corp. (NASDAQ:WGS) Revenue Forecasts By 11% - 富途牛牛
GeneDx Holdings' (NASDAQ:WGS) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
GENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
William Blair Investment Management, LLC's Strategic Acquisition in GeneDx Holdings Corp - GuruFocus
Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS) - GlobeNewswire
GeneDx Leadership to Present at 3 Premier Healthcare Conferences: Morgan Stanley, Wells Fargo, Canaccord - Stock Titan
GeneDx to Participate in Upcoming Investor Conferences - Business Wire
Piper Sandler reiterates Overweight rating on GeneDx stock, citing multiyear growth potential - Investing.com Canada
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication - ADVFN Brasil
How does GeneDx Holdings Corp. generate profit in a changing economyCapitalize on market momentum for big wins - Jammu Links News
What catalysts could drive GeneDx Holdings Corp. stock higher in 2025Maximize gains with expert analysis - Jammu Links News
Published on: 2025-08-04 06:03:13 - Jammu Links News
Is GeneDx Holdings Corp. stock overvalued or undervaluedHigh-margin investment plays - Jammu Links News
Published on: 2025-08-04 04:10:50 - Jammu Links News
What are analysts’ price targets for GeneDx Holdings Corp. Equity Warrant in the next 12 monthsTremendous gains - Jammu Links News
How many analysts rate GeneDx Holdings Corp. Equity Warrant as a “Buy”Discover high-growth stocks for your portfolio - Jammu Links News
Should I hold or sell GeneDx Holdings Corp. Equity Warrant stock in 2025Achieve rapid capital gains with smart investing - Jammu Links News
How volatile is GeneDx Holdings Corp. stock compared to the marketInvest with confidence backed by data - Jammu Links News
Is GeneDx Holdings Corp. Equity Warrant stock overvalued or undervaluedBuild a diversified portfolio for risk mitigation - Jammu Links News
How strong is GeneDx Holdings Corp. company’s balance sheetGet timely market insights for better trades - Jammu Links News
What institutional investors are buying GeneDx Holdings Corp. stockFree Daily Trading Room Entry - Jammu Links News
How strong is GeneDx Holdings Corp. Equity Warrant company’s balance sheetBuild your wealth with consistent stock growth - Jammu Links News
When is GeneDx Holdings Corp. Equity Warrant stock expected to show significant growthAchieve rapid returns with smart investment plans - Jammu Links News
What analysts say about GeneDx Holdings Corp. Equity Warrant stockSignificant capital appreciation - Jammu Links News
Is it the right time to buy GeneDx Holdings Corp. Equity Warrant stockUnlock daily market insights for better trades - Jammu Links News
Published on: 2025-08-03 12:13:18 - Jammu Links News
Why is GeneDx Holdings Corp. Equity Warrant stock attracting strong analyst attentionStrong return on assets - Jammu Links News
What are GeneDx Holdings Corp. Equity Warrant company’s key revenue driversOutstanding trading profits - Jammu Links News
GeneDx raises 2025 revenue guidance to $415M and exome/genome revenue growth to 52% while accelerating NICU and pediatric market expansion - MSN
GeneDx Reports Record Revenue and Growth in Q2 2025 - The Globe and Mail
GeneDx Holdings Corp. Executives Sell Shares for Tax Obligations - TradingView
GeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End Growth (NASDAQ:WGS) - Seeking Alpha
GeneDx Holdings Corp. (NASDAQ:WGS) Q2 2025 Earnings Call Transcript - Insider Monkey
What makes GeneDx Holdings Corp. Equity Warrant stock price move sharplyChart Pattern Guidance To Watch Now - Jammu Links News
Investigation into GeneDx Holdings Corp. for Securities Violations - AInvest
GeneDx investigated for securities law violations, allegedly fraudulent practices. - AInvest
WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group - PR Newswire
What makes GeneDx Holdings Corp. stock price move sharplyDaily Chart Pattern Stock Forecast Shows Bullish Setup - beatles.ru
Genedx Holdings Corp (WGS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
자본화:
|
볼륨(24시간):